Research progress of tumor-associated macrophages in immune checkpoint inhibitor tolerance in colorectal cancer

doi:10.4251/wjgo.v16.i10.4064

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (501)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series.

Item

Count

PDF

HTML

401

Figures (1-6)

Sum=453

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=34

Oct 15, 2024 (publication date) through Oct 19, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Oncol. Oct 15, 2024; 16(10): 4064-4079
Published online Oct 15, 2024. doi: 10.4251/wjgo.v16.i10.4064

Full Size Figure Download Figure

Figure 3 Targeting effector cells with bispecific antibodies for cancer therapy. NK: Natural killer; EPCAM: Epithelial cell adhesion molecule; PSMA: Prostate-specific membrane antigen; BCMA: Bulbospinal muscular atrophy.

Citation: Fan Q, Fu ZW, Xu M, Lv F, Shi JS, Zeng QQ, Xiong DH. Research progress of tumor-associated macrophages in immune checkpoint inhibitor tolerance in colorectal cancer. World J Gastrointest Oncol 2024; 16(10): 4064-4079
URL: https://www.wjgnet.com/1948-5204/full/v16/i10/4064.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i10.4064